JPMorgan keeps CHF 90.00 target for Bachem stock

Published on 10/15/2026 at 20:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

In the first half of 2026, sales reached CHF 326.40 million, up 4.00 percent. Bachem stock costs EUR 90.78 on October 15, 2026 at 8:38 p.m. CEST.

Analyst view and reporting date

JPMorgan maintained a CHF 90.00 target for Bachem on September 10, 2026.
Bachem reported CHF 326.40 million in first-half 2026 sales, up 4.00 percent year over year.
Bachem stock costs EUR 90.78 at Lang & Schwarz on October 15, 2026 at 8:38 p.m. CEST.
Bachem's next earnings report is scheduled for March 4, 2027.

Fotorealistische Peptid-Produktionsanlage mit Alpenpanorama im Hintergrund — Bachem Holding AG (CH0012530207) betreibt moderne Peptid-Produktionsanlagen mit Bioreaktoren vor Schweizer Alpenpanorama, Illustration mit AI erstellt.

Bachem stock has a CHF 90.00 target from JPMorgan, which maintained the figure on September 10, 2026, according to Investing.com. Against Bachem's CHF 84.20 last price on SIX on October 15, 2026, the target stands 6.89 percent higher. Bachem stock was trading at EUR 90.78 at Lang & Schwarz on October 15, 2026 at 8:38 p.m. CEST.

Half-year sales rose 4.00 percent

Bachem reported CHF 326.40 million in sales for the first half of 2026, a 4.00 percent increase from the first half of 2025. The figure came with CHF 82.80 million of EBIT and a 25.40 percent EBITDA margin, according to the company's half-year earnings call carried by Yahoo Finance on July 30, 2026. The same call described sales growth of 7.30 percent in local currencies, separating currency effects from operating progress.

Range and trading activity

Bachem's CHF 84.20 SIX price matched its reported 52-week high of CHF 84.20 on October 15, 2026, while the low stood at CHF 48.52. Trading volume reached 129,364 shares, compared with an average of 105,759, making the session volume 22.33 percent higher than average. The company's market capitalization was CHF 6.3 billion, and its price-to-earnings ratio was 42.31.

Valuation and next date

The JPMorgan target sits above the latest SIX price, while the broader analyst table lists 10 analysts and an average 12-month target of CHF 84.30. Bachem's next earnings report is listed for March 4, 2027, by TradingView. That date gives the market a defined checkpoint after the half-year figures.

Comparison with peers

Bachem: P/E 42.31, market capitalization CHF 6.3 billion

Siegfried Holding (SIX, CHF): plus 0.57 percent, P/E 17.90, market capitalization CHF 3.1 billion

Lonza Group (SIX, CHF): plus 3.14 percent, market capitalization CHF 42.2 billion

Price after the Xetra session

The Lang & Schwarz euro quote places Bachem above its SIX price in nominal terms, but the two quotations use different currencies and venues. The SIX quotation was last at CHF 84.20 on October 15, 2026 at 5:31 p.m. CEST, while the euro quote remained active in after-hours trading.

The further course of trading is shown by the continuously updated real-time quote of Bachem stock.